2BB score and signals
Anavex Life Sciences Corp.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 33 | Weak |
| Quality | 60 | Strong |
| Risk | 39 | Low |
Company facts
| CEO | Christopher U. Missling Ph.D. |
| Headquarters | New York, New York, United States |
| Founded | 2004 |
| Employees | 34 |
| 52-week range | $2.26 – $10.64 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-08 | — | -0.1224 | — | — |
| 2026-11-23 | — | -0.1122 | — | $0.00 |
| 2026-08-10 | — | -0.0816 | — | $0.00 |
| 2026-05-07 | — | -0.0765 | — | $0.00 |
Related companies
